Novo led a €29m Series C funding round in AMSilk.

Novo Group, a life science investor, led a €29m Series C funding round in AMSilk, an industrial supplier of synthetic silk biopolymer, with participation from new investors Cargill and E.R. Capital Holdings as well as existing investors MIG Verwaltungs and ATHOS. “Together with our customers we work to create high-performance bio-based materials with the potential to revolutionize product offerings and drive change across various industries. It is exciting to have the support from high-technology investors, led by Novo Holdings, to make our silk polymers available in industrial quantities to an even broader range of customers and industries,” Ulrich Scherbel, AMSilk Chief Executive Officer.